Soluble perlecan domain i enhances vascular endothelial growth factor-165 activity and receptor phosphorylation in human bone marrow endothelial cells

Por Muthusamy, Arivalagan, Cooper, Carlton R, Gomes, Ronald R
Publicado em 2010

P2Y2 RECEPTORS AND GRK2 ARE INVOLVED IN OSCILLATORY FLUID FLOW INDUCED ERK1/2 RESPONSES IN CHONDROCYTES

Por Xing, Yanghui, Gu, Yan, Gomes, Ronald R., You, Jun
Publicado em 2010

Perlecan-Stimulated Nodules Undergo Chondrogenic Maturation in Response to rhBMP-2 Treatment In Vitro

Por Gomes, Ronald R., Carson, Mary C. Farach, Carson, Daniel D.
Publicado em 2003

Ribozyme-Mediated Perlecan Knockdown Impairs Chondrogenic Differentiation of C3H10T1/2 Fibroblasts

Por Gomes, Ronald R., Joshi, Sonali S., Farach-Carson, Mary C., Carson, Daniel D.
Publicado em 2006

Chondrogenic Activity of the Heparan Sulfate Proteoglycan Perlecan Maps to the N-terminal Domain I

Por FRENCH, MARGARET M., GOMES, RONALD R., TIMPL, RUPERT, HÖÖK, MAGNUS, CZYMMEK, KIRK, FARACH-CARSON, MARY C., CARSON, DANIEL D.
Publicado em 2002

Chondrogenic Differentiation on Perlecan Domain I, Collagen II and Bone Morphogenetic Protein 2-Based Matrices

Por Yang, Weidong, Gomes, Ronald R., Brown, Anissa J., Burdett, Ashley R., Alicknavitch, Michael, Farach-Carson, Mary C., Carson, Daniel D.
Publicado em 2006